Chanan-Khan AA, Lonial S, Weber D, Borrello I, Foa R, Hellmann A, Dimopoulos M, Swern AS, Knight R. Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ?65 years old with relapsed or refractory multiple myeloma. International Journal of Hematology [Internet]. 2012;96(2):254 - 262.